MAPT and Mental deterioration: We show here that cisplatin induced tau hyperphosphorylation in the DG and CA1 regions of the hippocampus, a phenomenon that correlate with onset of cognitive decline in AD and other tauopathy models [19, 38], and that ACY-1083 treatment reversed tau hyperphosphorylation.